Teoxane España

What Teoxane España does

Teoxane España, legally constituted as TEOXANE IBERICA S.R.L, is the Iberian distribution subsidiary of Laboratorios TEOXANE, a Geneva-based medical aesthetics company founded in 2003 by Valérie Taupin. From its headquarters in Valencia, the Spanish entity distributes Swiss-manufactured hyaluronic acid dermal fillers and dermocosmetic products to licensed medical professionals — primarily dermatologists, aesthetic doctors, and aesthetic clinics — across Spain, Portugal, and Andorra. The company's customer model is strictly professional-only, with the website bifurcating visitors into 'Soy médico' (I am a doctor) and 'No soy médico' pathways, signaling that consumers are routed to partner clinics rather than purchasing directly.

The core technology is RHA® (Resilient Hyaluronic Acid) — a cross-linked hyaluronic acid formulation developed and manufactured in the parent's integrated Geneva facility, designed to maintain properties similar to the body's own hyaluronic acid and to remain synchronized with facial dynamics. The commercial product portfolio centers on the Teosyal RHA® dermal filler range, complemented by a Teoxane Dermocosmetics skincare line that uses the same cross-linked hyaluronic acid technology for at-home daily anti-aging use, and the Teoxane Play streaming education platform for medical aesthetics professionals. The broader product narrative is anchored in the 'Belleza Dinámica' brand philosophy launched in 2021.

Teoxane España generates revenue primarily through direct B2B sales of dermal fillers and dermocosmetics to professional buyers, with payment terms of 30-day direct debit and temperature-controlled delivery across Spain, Portugal, and Andorra. Free shipping applies to orders of €700 or above; orders below €700 incur a €24 shipping charge. Distribution operates through a direct field-sales motion and the Teoxane Shop e-commerce storefront. A network of collaborating clinics receives customer inquiry data to facilitate treatment bookings, indicating a hybrid direct-plus-referral model. No external investors are disclosed; ownership is fully retained by the Swiss parent company.

Name

Teoxane España

Legal name

TEOXANE IBERICA S.R.L

Website

https://teoxane.es

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Teoxane España is the Iberian distribution subsidiary of Swiss medical aesthetics company Laboratorios TEOXANE, selling Teosyal RHA® hyaluronic acid dermal fillers, dermocosmetic skincare, and the Teoxane Play training platform to licensed medical professionals across Spain, Portugal, and Andorra.

Ownership category

akta.pro rank

Product category

Aesthetic Medicine Dermal Fillers

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Hyaluronic acid dermal fillers
• Aesthetic medicine products
• Medical professional skincare
• Dermocosmetic product lines
• Injectable aesthetic treatments

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel

Revenue model

1. Dermal Filler Product Sales: Teoxane generates revenue through the sale of hyaluronic acid dermal fillers (Teosyal RHA® product line) and dermocosmetic products to professional medical buyers (clinics, aesthetic doctors, dermatologists). Products are sold in Spain, Portugal, and Andorra with temperature-controlled delivery. Orders under €700 incur a €24 shipping charge.
2. Teoxane Play Training Platform: Online streaming and on-demand platform for medical aesthetic training and sector innovations. While primarily a training resource for medical professionals, it serves as a customer acquisition and retention tool for the Teosyal product range.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Teoxane España is the Spanish subsidiary of Teoxane Laboratories (Geneva, Switzerland), selling Teosyal RHA® hyaluronic acid dermal fillers, a complementary dermocosmetic skincare line, and the Teoxane Play online training platform directly to licensed medical professionals and aesthetic clinics across Spain, Portugal, and Andorra.

Product overview

Teoxane España operates as the Spanish subsidiary of Teoxane Laboratories (Ginebra, Suiza), founded in 2003 by Valérie Taupin. The company's product portfolio centers on Teosyal RHA® (Resilient Hyaluronic Acid) dermal fillers - a complete range designed to treat wrinkles, add volume, and improve skin quality. Complementing the injectable range, Teoxane offers a dermocosmetic product line using the same cross-linked hyaluronic acid technology for at-home skincare. The company also provides Teoxane Play, a streaming education platform for medical aesthetics professionals. The offering follows the 'Belleza Dinámica' (Dynamic Beauty) philosophy - a natural, judgment-free approach to aesthetic medicine.

Differentiator

Problem solved

Functional benefit

Brands

• Teoxane Play: Online streaming and on-demand platform for medical aesthetics professionals providing training content and industry news.
• Belleza Dinámica

Products and services

• Teosyal RHA® Dermal Fillers Complete range of hyaluronic acid dermal fillers designed to treat wrinkles and specific facial areas, add volume, and improve skin quality. The RHA® (Resilient Hyaluronic Acid) formulation is designed to work synchronously with facial expressions for natural and undetectable results. Sold to licensed medical professionals and aesthetic clinics.
• Teoxane Dermocosmetic Product Line Complementary cosmeceutical range using cross-linked hyaluronic acid similar to the dermal filler formulation, designed for patients who have undergone medical aesthetic procedures and wish to continue with home care, as well as those seeking daily anti-aging skincare inspired by Swiss science.

Quantifiable outcome

• Results demonstrated up to 18 months after injection with outstanding performance, duration, and safety in comparative clinical studies

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Collaborating Clinics (Clínicas Colaboradoras)coreChannel Partner/ Reseller/ DistributorTeoxane shares customer inquiry data with collaborating clinics for the purpose of facilitating treatment bookings and appointments. The clinics receive contact information from Teoxane to improve their services to customers and their commercial operations. This data sharing enables Teoxane to connect potential patients with qualified aesthetic treatment providers in their network.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Sinclair Pharma: Aesthetics company offering hyaluronic-acid fillers (MaiLi) plus complementary skin-quality products, distributed through medical professionals in Europe. Direct comparable in portfolio mix and channel model.
• Merz Aesthetics: Markets the Belotero range of HA fillers and Radiesse (CaHA), selling through dermatologists and aesthetic clinics. Closely comparable in technology positioning and professional-only GTM to Teoxane.
• Croma-Pharma: Austrian-based aesthetics company selling a hyaluronic-acid filler portfolio (saypha/Princess) to medical professionals across Europe. Comparable European-anchored HA-filler competitor with similar professional-only distribution.
• Laboratoires Vivacy: French manufacturer of hyaluronic-acid-based dermal fillers (Stylage range) sold through medical professionals across Europe. Closely comparable European-based HA-filler specialist with similar practitioner channel.
• Galderma: Global leader in aesthetic dermatology with the Restylane hyaluronic-acid filler portfolio. Direct competitor to Teoxane's Teosyal RHA® range, selling to the same medical-professional channel across Europe and worldwide.

Emerging players

• Evolus: Aesthetics company marketing injectable products (Jeuveau and partnering on fillers) to medical professionals. Comparable in channel strategy targeting aesthetic practitioners, though with a neuromodulator-led portfolio.
• Revance Therapeutics: US aesthetics company (Daxxify, RHA Collection rights) competing in HA fillers and neuromodulators with novel delivery technology. Overlaps with Teoxane in the HA-filler category and shares the medical-professional-only sales model.

Broad incumbents

• Allergan Aesthetics (AbbVie): Owner of the Juvéderm hyaluronic-acid filler franchise, the largest direct competitor in HA injectables globally. Operates a much broader aesthetics portfolio (Botox, Coolsculpting, Latisse) and competes head-to-head with Teoxane in medical-professional channels.
• Bloomage Biotechnology: Chinese-based hyaluronic-acid raw-material and finished-product company supplying both B2B ingredients and consumer/medical skincare lines. Comparable through its HA-based skincare/filler activities and global distribution ambition.

Regional players

• Mesoestetic Pharmaceutical Group: Spanish-headquartered dermocosmetics and medical-aesthetics company selling through aesthetic clinics in Spain and internationally. Comparable in product mix (professional skincare + injectable-adjacent range) and Iberian market overlap.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/teoxane-spain

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Teoxane España